PATENT CLAIM ANALYSIS

Application Number: 16068255
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "304000"]

Abstract:
The present invention relates to treatment of hypertension using a combination of tesofensine and metoprolol. The treatment is particularly well suited for the treatment of hypertensive obese subjects and hypertensive diabetic subjects.

Claim (Index 11):
The method according to  claim 1 , wherein the subject is obese, prior to the administration.

Metadata:
- Claim Count in Document: 96.0
- Percentile: 95.0
- Lexical Diversity: 1.36
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14936963', '14379032', '15058533', '15554449', '15491870']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7600442244408366
- 35 USC 102 Novelty (BERT): 0.5549446738104538
- Combined Prediction Score: 0.7395342693777983
- Mean Citation Score: 349.07071000000013
- Max Citation Score: 435.78998
- Similarity Product: 315.31878465024465

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test